Consequences of targeted treatments for second-line therapy.

MLA

De Maio, E., et al. “Consequences of Targeted Treatments for Second-Line Therapy.” Annals of Oncology : Official Journal of the European Society for Medical Oncology, vol. 21 Suppl 7, Oct. 2010, pp. vii234-vii240. EBSCOhost, https://doi.org/10.1093/annonc/mdq280.

APA

De Maio, E., Tibaldi, C., D’Incecco, A., Bursi, S., Barbara, C., Cupini, S., Di Marsico, R., D’Arcangelo, M., Landi, L., Minuti, G., & Cappuzzo, F. (2010). Consequences of targeted treatments for second-line therapy. Annals of Oncology : Official Journal of the European Society for Medical Oncology, 21 Suppl 7, vii234-vii240. https://doi.org/10.1093/annonc/mdq280

Chicago

De Maio, E, C Tibaldi, A D’Incecco, S Bursi, C Barbara, S Cupini, R Di Marsico, et al. 2010. “Consequences of Targeted Treatments for Second-Line Therapy.” Annals of Oncology : Official Journal of the European Society for Medical Oncology 21 Suppl 7 (October): vii234-vii240. doi:10.1093/annonc/mdq280.